C.R. Bard (BCR) 169.14 $BCR CR Bard's Lutonix D
Post# of 64200
Posted On: 02/28/2015 7:31:38 PM
C.R. Bard (BCR) 169.14 $BCR
CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 5:14PM CST
Following a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel, the CMS has approved a pass-through payment for CR Bard Inc.'s (BCR) Lutonix DCB.
HYH: 46.04 (-0.77), BSX: 16.90 (+0.08), ABC: 102.76 (-0.22), BCR: 169.14 (-1.80)
The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST
ELLI: 52.85 (-0.39), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), CIEN: 20.92 (+0.01), AET: 99.55 (+0.24), ANAC: 43.50 (-0.60), CSL: 93.07 (-1.11), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), DEPO: 21.95 (-0.65), HRL: 58.51 (+0.05), CSX: 34.31 (unch), DYAX: 15.11 (-0.37), LVLT: 53.86 (+0.47), CBRL: 151.03 (+0.01), MTSI: 33.72 (-0.27), AZO: 642.68 (-2.29), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), FSL: 36.11 (+0.14), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), DLX: 66.55 (-1.40), ABT: 47.37 (-0.24), ENDP: 85.60 (+0.36), ABCO: 54.12 (-0.43), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), IGV: 98.31 (-0.43), CTAS: 83.48 (-0.53), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), FLO: 21.64 (+0.21), CRM: 69.38 (-0.86)
The Best Large Cap Stocks To Buy In Portfolios
Todd Campbell - at Seeking Alpha - Thu Feb 19, 6:43AM CST
OCR: 76.74 (-0.07), CAH: 87.99 (-0.18), PSA: 197.22 (+0.46), SLG: 126.93 (+1.17), AET: 99.55 (+0.24), VTR: 74.47 (+0.69), HSIC: 140.05 (-0.39), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), OTEX: 58.22 (-0.96), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), HRL: 58.51 (+0.05), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), BA: 150.85 (-0.88), NVDA: 22.06 (-0.14), LVLT: 53.86 (+0.47), AZO: 642.68 (-2.29), AVB: 168.34 (+2.11), SIAL: 138.06 (unch), SPLK: 67.25 (-2.32), FSL: 36.11 (+0.14), ASH: 127.62 (-1.59), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), AON: 100.36 (+0.14), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), V: 271.31 (-2.44), Q: 64.98 (+0.03), APD: 156.14 (-0.49), PII: 153.33 (-4.29), ENDP: 85.60 (+0.36), ABT: 47.37 (-0.24), HCN: 77.11 (+1.04), ORLY: 208.13 (-1.21), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), CTAS: 83.48 (-0.53), PLL: 100.81 (-0.80), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), CRM: 69.38 (-0.86)
CryoLife (CRY) Down as Q4 Earnings Fall; Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:03AM CST
CryoLife Inc. (CRY) reported adjusted earnings per share (EPS) of 4 cents in the fourth quarter of 2014, lower than the year-ago equivalent of 7 cents.
ABMD: 60.79 (-0.21), BCR: 169.14 (-1.80), LMNX: 15.74 (-0.23), CRY: 10.48 (-0.24)
The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 15, 1:02PM CST
OCR: 76.74 (-0.07), ELLI: 52.85 (-0.39), CAG: 34.98 (+0.31), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), AET: 99.55 (+0.24), PKG: 82.86 (+0.15), CAKE: 47.52 (-1.13), DAN: 21.85 (-0.17), CSL: 93.07 (-1.11), AAN: 29.81 (+0.14), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), COLM: 55.89 (-0.13), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), LVLT: 53.86 (+0.47), PFPT: 56.64 (-0.69), AZO: 642.68 (-2.29), IRWD: 15.45 (-0.58), HAE: 44.46 (-0.79), EL: 82.67 (+0.39), FSL: 36.11 (+0.14), ACT: 291.36 (+1.58), BDX: 146.72 (-1.82), BLL: 71.71 (-0.71), BWLD: 191.12 (-0.62), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), DPS: 78.79 (+0.60), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), GMED: 24.28 (-0.78), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), HBI: 127.54 (-1.37), DLX: 66.55 (-1.40), ORLY: 208.13 (-1.21), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), DISH: 75.04 (-1.72), LEA: 108.92 (-0.11), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), PERY: 23.60 (+0.02), CTAS: 83.48 (-0.53), BIG: 47.71 (-0.02)
CR Bard: Under The Radar Safety In Healthcare?
Michael Boyd - at Seeking Alpha - Thu Feb 12, 7:18AM CST
BCR: 169.14 (-1.80)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 46.04 (-0.77), BSX: 16.90 (+0.08), BCR: 169.14 (-1.80), BRLI: 34.94 (-0.30)
CR Bard Set to Possibly Rebound After Yesterday's Selloff of 1.80%
Comtex SmarTrend(R) - Mon Feb 09, 4:41PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.62 to a high of $171.85. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $171.46 on volume of 923,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
After Yesterday's Decline of 1.80%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Mon Feb 09, 4:41PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.62 to a high of $171.85. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $171.46 on volume of 923,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST
MNK: 116.72 (-2.89), BIIB: 409.59 (-0.51), VRX: 197.48 (-3.77), BCR: 169.14 (-1.80), EVHC: 36.62 (-0.93), TMO: 130.00 (-0.14), CAH: 87.99 (-0.18), UTHR: 155.05 (-0.53), ILMN: 195.46 (-3.00), ACOR: 33.84 (-1.72), LCI: 62.40 (-2.77), JAZZ: 170.09 (-5.10), SHPG: 241.91 (-5.93), CPHD: 56.84 (-1.60), SYK: 94.75 (+0.35)
Boston Scientific signs up to distribute Bard DCB
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 10:46AM CST
BSX: 16.90 (+0.08), BCR: 169.14 (-1.80)
Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon
PR Newswire - Mon Feb 09, 8:00AM CST
Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard"
today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States under a limited distribution agreement reached with Bard. Terms of the agreement were not disclosed.
BSX: 16.90 (+0.08), BCR: 169.14 (-1.80)
Comparing America's 3 Largest Medical Instruments And Supplies Companies
Joseph Cafariello - at Seeking Alpha - Wed Feb 04, 1:53PM CST
BDX: 146.72 (-1.82), BCR: 169.14 (-1.80), BAX: 69.15 (+0.48)
'Mad Money' Lightning Round: Buy, Buy, Buy Fiat, It's Sensation
at The Street - Wed Feb 04, 5:00AM CST
Cramer says to avoid Tyson Foods and take Facebook or Google over Micron Technology.
MU: 30.67 (+0.05), BCR: 169.14 (-1.80), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), TSN: 41.31 (+0.44), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Chicken Is A Commodity - Cramer's Lightning Round (2/3/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Feb 04, 4:40AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 3. Bullish Calls: Celgene (NASDAQ: CELG ): Cramer said Celgene is going lower because the entire group is going lower. " There is a big...
MU: 30.67 (+0.05), BCR: 169.14 (-1.80), ETN: 71.01 (-0.78), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), GOOG: 558.40 (+2.92), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Jim Cramer's 'Mad Money' Recap: What a Difference a Month Makes
at The Street - Tue Feb 03, 7:19PM CST
In January the market was breaking bad. In February, it's breaking good in a big way, Cramer says.
KMI: 41.01 (-0.21), MU: 30.67 (+0.05), AA: 14.79 (-0.32), ETN: 71.01 (-0.78), BCR: 169.14 (-1.80), HON: 102.78 (-0.86), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), TSN: 41.31 (+0.44), FTNT: 33.61 (-0.44), AAPL: 128.46 (-1.95), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Nuveen's Bob Doll Runs Several Top Funds
at Investor's Business Daily - Tue Feb 03, 5:22PM CST
Bob Doll runs an all-star team. Five Nuveen Asset Management stock mutual funds he runs rank in the top 130 U.S. diversified stock funds based on trailing 12-month performance through Jan. 31, according to Morningstar Inc. His $100 million...
HII: 141.33 (-1.31), BIIB: 409.59 (-0.51), GD: 138.78 (-0.65), GE: 25.99 (+0.10), LMT: 200.05 (-1.28), G: 22.22 (+0.03), BCR: 169.14 (-1.80), AMGN: 157.72 (-1.25), GLW: 24.40 (-0.07), ANTM: 146.45 (-0.27), GILD: 103.53 (-0.66), GPS: 41.60 (+1.23), MSFT: 43.85 (-0.21), AAPL: 128.46 (-1.95), MA: 90.13 (-1.13)
Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
Brian Ditchek - at Seeking Alpha - Tue Feb 03, 10:01AM CST
MKC: 75.38 (unch), GPC: 96.08 (-0.45), CAH: 87.99 (-0.18), ED: 63.14 (+0.08), SYY: 38.99 (-0.15), WMT: 83.93 (+0.13), GWW: 236.91 (-3.47), PNR: 66.47 (-0.87), TGT: 76.83 (-0.07), ABBV: 60.50 (-0.02), LOW: 74.09 (-0.01), BCR: 169.14 (-1.80), TROW: 82.60 (-0.72), VFC: 76.66 (-0.22), FDO: 78.74 (+0.13), HRL: 58.51 (+0.05), MHFI: 103.10 (-0.39), ADP: 88.84 (unch), ADM: 47.88 (+0.33), SIAL: 138.06 (unch), MCD: 98.90 (-0.61), DOV: 72.05 (-0.47), CVX: 106.68 (-0.38), SHW: 285.20 (-2.50), BF.B: 91.69 (-0.73), MMM: 168.65 (-0.96), BDX: 146.72 (-1.82), CLX: 108.64 (-0.46), MDT: 77.59 (-1.22), KMB: 109.66 (-0.25), XOM: 88.54 (-0.11), CB: 100.45 (-0.21), PEP: 98.98 (-0.09), SWK: 98.34 (-0.30), JNJ: 102.51 (-0.29), T: 34.56 (+0.06), CINF: 52.76 (-0.25), PPG: 235.38 (-0.46), APD: 156.14 (-0.49), ECL: 115.54 (-0.61), KO: 43.30 (+0.84), ABT: 47.37 (-0.24), HCP: 42.36 (+0.58), NUE: 47.03 (-0.23), EMR: 57.92 (-0.02), LEG: 45.05 (-0.03), ITW: 98.86 (-0.45), CTAS: 83.48 (-0.53), PG: 85.13 (-0.04), BEN: 53.83 (-0.69), AFL: 62.25 (+0.07), CL: 70.82 (-0.29)
Tracking Yacktman Asset Management Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Tue Feb 03, 4:03AM CST
BDX: 146.72 (-1.82), CHRW: 74.30 (+0.09), CLX: 108.64 (-0.46), SYY: 38.99 (-0.15), XOM: 88.54 (-0.11), WMT: 83.93 (+0.13), PDCO: 50.08 (+0.64), PEP: 98.98 (-0.09), ANTM: 146.45 (-0.27), JNJ: 102.51 (-0.29), FOX: 34.04 (+0.25), EBAY: 57.91 (-0.63), FOXA: 35.00 (+0.19), MSFT: 43.85 (-0.21), NWS: 16.82 (-0.04), BK: 39.14 (-0.30), CSCO: 29.51 (-0.40), SYK: 94.75 (+0.35), KO: 43.30 (+0.84), AVP: 8.51 (+0.12), STT: 74.45 (-0.36), BCR: 169.14 (-1.80), UN: 43.47 (+0.22), COP: 65.20 (-0.65), WFC: 54.79 (-0.36), HPQ: 34.84 (+0.83), ORCL: 43.82 (-0.07), USB: 44.61 (-0.32), SIAL: 138.06 (unch), MRK: 58.54 (-0.42), PG: 85.13 (-0.04), VIAB: 69.94 (+0.33), CMCSA: 59.38 (+0.23)
Watch for CR Bard to Potentially Rebound After Falling 3.34% Yesterday
Comtex SmarTrend(R) - Fri Jan 30, 4:13PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.83 to a high of $176.49. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $173.53 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 23, 5:14PM CST
Following a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel, the CMS has approved a pass-through payment for CR Bard Inc.'s (BCR) Lutonix DCB.
HYH: 46.04 (-0.77), BSX: 16.90 (+0.08), ABC: 102.76 (-0.22), BCR: 169.14 (-1.80)
The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST
ELLI: 52.85 (-0.39), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), CIEN: 20.92 (+0.01), AET: 99.55 (+0.24), ANAC: 43.50 (-0.60), CSL: 93.07 (-1.11), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), DEPO: 21.95 (-0.65), HRL: 58.51 (+0.05), CSX: 34.31 (unch), DYAX: 15.11 (-0.37), LVLT: 53.86 (+0.47), CBRL: 151.03 (+0.01), MTSI: 33.72 (-0.27), AZO: 642.68 (-2.29), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), FSL: 36.11 (+0.14), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), DLX: 66.55 (-1.40), ABT: 47.37 (-0.24), ENDP: 85.60 (+0.36), ABCO: 54.12 (-0.43), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), IGV: 98.31 (-0.43), CTAS: 83.48 (-0.53), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), FLO: 21.64 (+0.21), CRM: 69.38 (-0.86)
The Best Large Cap Stocks To Buy In Portfolios
Todd Campbell - at Seeking Alpha - Thu Feb 19, 6:43AM CST
OCR: 76.74 (-0.07), CAH: 87.99 (-0.18), PSA: 197.22 (+0.46), SLG: 126.93 (+1.17), AET: 99.55 (+0.24), VTR: 74.47 (+0.69), HSIC: 140.05 (-0.39), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), OTEX: 58.22 (-0.96), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), HRL: 58.51 (+0.05), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), BA: 150.85 (-0.88), NVDA: 22.06 (-0.14), LVLT: 53.86 (+0.47), AZO: 642.68 (-2.29), AVB: 168.34 (+2.11), SIAL: 138.06 (unch), SPLK: 67.25 (-2.32), FSL: 36.11 (+0.14), ASH: 127.62 (-1.59), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), AON: 100.36 (+0.14), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), V: 271.31 (-2.44), Q: 64.98 (+0.03), APD: 156.14 (-0.49), PII: 153.33 (-4.29), ENDP: 85.60 (+0.36), ABT: 47.37 (-0.24), HCN: 77.11 (+1.04), ORLY: 208.13 (-1.21), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), CTAS: 83.48 (-0.53), PLL: 100.81 (-0.80), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), CRM: 69.38 (-0.86)
CryoLife (CRY) Down as Q4 Earnings Fall; Revenues Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:03AM CST
CryoLife Inc. (CRY) reported adjusted earnings per share (EPS) of 4 cents in the fourth quarter of 2014, lower than the year-ago equivalent of 7 cents.
ABMD: 60.79 (-0.21), BCR: 169.14 (-1.80), LMNX: 15.74 (-0.23), CRY: 10.48 (-0.24)
The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 15, 1:02PM CST
OCR: 76.74 (-0.07), ELLI: 52.85 (-0.39), CAG: 34.98 (+0.31), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), AET: 99.55 (+0.24), PKG: 82.86 (+0.15), CAKE: 47.52 (-1.13), DAN: 21.85 (-0.17), CSL: 93.07 (-1.11), AAN: 29.81 (+0.14), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), COLM: 55.89 (-0.13), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), LVLT: 53.86 (+0.47), PFPT: 56.64 (-0.69), AZO: 642.68 (-2.29), IRWD: 15.45 (-0.58), HAE: 44.46 (-0.79), EL: 82.67 (+0.39), FSL: 36.11 (+0.14), ACT: 291.36 (+1.58), BDX: 146.72 (-1.82), BLL: 71.71 (-0.71), BWLD: 191.12 (-0.62), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), DPS: 78.79 (+0.60), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), GMED: 24.28 (-0.78), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), HBI: 127.54 (-1.37), DLX: 66.55 (-1.40), ORLY: 208.13 (-1.21), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), DISH: 75.04 (-1.72), LEA: 108.92 (-0.11), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), PERY: 23.60 (+0.02), CTAS: 83.48 (-0.53), BIG: 47.71 (-0.02)
CR Bard: Under The Radar Safety In Healthcare?
Michael Boyd - at Seeking Alpha - Thu Feb 12, 7:18AM CST
BCR: 169.14 (-1.80)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 46.04 (-0.77), BSX: 16.90 (+0.08), BCR: 169.14 (-1.80), BRLI: 34.94 (-0.30)
CR Bard Set to Possibly Rebound After Yesterday's Selloff of 1.80%
Comtex SmarTrend(R) - Mon Feb 09, 4:41PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.62 to a high of $171.85. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $171.46 on volume of 923,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
After Yesterday's Decline of 1.80%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Mon Feb 09, 4:41PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.62 to a high of $171.85. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $171.46 on volume of 923,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST
MNK: 116.72 (-2.89), BIIB: 409.59 (-0.51), VRX: 197.48 (-3.77), BCR: 169.14 (-1.80), EVHC: 36.62 (-0.93), TMO: 130.00 (-0.14), CAH: 87.99 (-0.18), UTHR: 155.05 (-0.53), ILMN: 195.46 (-3.00), ACOR: 33.84 (-1.72), LCI: 62.40 (-2.77), JAZZ: 170.09 (-5.10), SHPG: 241.91 (-5.93), CPHD: 56.84 (-1.60), SYK: 94.75 (+0.35)
Boston Scientific signs up to distribute Bard DCB
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 10:46AM CST
BSX: 16.90 (+0.08), BCR: 169.14 (-1.80)
Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon
PR Newswire - Mon Feb 09, 8:00AM CST
Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard"
today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States under a limited distribution agreement reached with Bard. Terms of the agreement were not disclosed. BSX: 16.90 (+0.08), BCR: 169.14 (-1.80)
Comparing America's 3 Largest Medical Instruments And Supplies Companies
Joseph Cafariello - at Seeking Alpha - Wed Feb 04, 1:53PM CST
BDX: 146.72 (-1.82), BCR: 169.14 (-1.80), BAX: 69.15 (+0.48)
'Mad Money' Lightning Round: Buy, Buy, Buy Fiat, It's Sensation
at The Street - Wed Feb 04, 5:00AM CST
Cramer says to avoid Tyson Foods and take Facebook or Google over Micron Technology.
MU: 30.67 (+0.05), BCR: 169.14 (-1.80), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), TSN: 41.31 (+0.44), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Chicken Is A Commodity - Cramer's Lightning Round (2/3/15)
SA Editor Mohit Manghnani - Seeking Alpha - Wed Feb 04, 4:40AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 3. Bullish Calls: Celgene (NASDAQ: CELG ): Cramer said Celgene is going lower because the entire group is going lower. " There is a big...
MU: 30.67 (+0.05), BCR: 169.14 (-1.80), ETN: 71.01 (-0.78), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), GOOG: 558.40 (+2.92), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Jim Cramer's 'Mad Money' Recap: What a Difference a Month Makes
at The Street - Tue Feb 03, 7:19PM CST
In January the market was breaking bad. In February, it's breaking good in a big way, Cramer says.
KMI: 41.01 (-0.21), MU: 30.67 (+0.05), AA: 14.79 (-0.32), ETN: 71.01 (-0.78), BCR: 169.14 (-1.80), HON: 102.78 (-0.86), FB: 78.97 (-1.44), EW: 133.02 (-1.88), GM: 37.31 (-0.25), GOOGL: 562.63 (+3.34), FCAU: 15.41 (-0.06), TSN: 41.31 (+0.44), FTNT: 33.61 (-0.44), AAPL: 128.46 (-1.95), APD: 156.14 (-0.49), CELG: 121.53 (-1.82)
Nuveen's Bob Doll Runs Several Top Funds
at Investor's Business Daily - Tue Feb 03, 5:22PM CST
Bob Doll runs an all-star team. Five Nuveen Asset Management stock mutual funds he runs rank in the top 130 U.S. diversified stock funds based on trailing 12-month performance through Jan. 31, according to Morningstar Inc. His $100 million...
HII: 141.33 (-1.31), BIIB: 409.59 (-0.51), GD: 138.78 (-0.65), GE: 25.99 (+0.10), LMT: 200.05 (-1.28), G: 22.22 (+0.03), BCR: 169.14 (-1.80), AMGN: 157.72 (-1.25), GLW: 24.40 (-0.07), ANTM: 146.45 (-0.27), GILD: 103.53 (-0.66), GPS: 41.60 (+1.23), MSFT: 43.85 (-0.21), AAPL: 128.46 (-1.95), MA: 90.13 (-1.13)
Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
Brian Ditchek - at Seeking Alpha - Tue Feb 03, 10:01AM CST
MKC: 75.38 (unch), GPC: 96.08 (-0.45), CAH: 87.99 (-0.18), ED: 63.14 (+0.08), SYY: 38.99 (-0.15), WMT: 83.93 (+0.13), GWW: 236.91 (-3.47), PNR: 66.47 (-0.87), TGT: 76.83 (-0.07), ABBV: 60.50 (-0.02), LOW: 74.09 (-0.01), BCR: 169.14 (-1.80), TROW: 82.60 (-0.72), VFC: 76.66 (-0.22), FDO: 78.74 (+0.13), HRL: 58.51 (+0.05), MHFI: 103.10 (-0.39), ADP: 88.84 (unch), ADM: 47.88 (+0.33), SIAL: 138.06 (unch), MCD: 98.90 (-0.61), DOV: 72.05 (-0.47), CVX: 106.68 (-0.38), SHW: 285.20 (-2.50), BF.B: 91.69 (-0.73), MMM: 168.65 (-0.96), BDX: 146.72 (-1.82), CLX: 108.64 (-0.46), MDT: 77.59 (-1.22), KMB: 109.66 (-0.25), XOM: 88.54 (-0.11), CB: 100.45 (-0.21), PEP: 98.98 (-0.09), SWK: 98.34 (-0.30), JNJ: 102.51 (-0.29), T: 34.56 (+0.06), CINF: 52.76 (-0.25), PPG: 235.38 (-0.46), APD: 156.14 (-0.49), ECL: 115.54 (-0.61), KO: 43.30 (+0.84), ABT: 47.37 (-0.24), HCP: 42.36 (+0.58), NUE: 47.03 (-0.23), EMR: 57.92 (-0.02), LEG: 45.05 (-0.03), ITW: 98.86 (-0.45), CTAS: 83.48 (-0.53), PG: 85.13 (-0.04), BEN: 53.83 (-0.69), AFL: 62.25 (+0.07), CL: 70.82 (-0.29)
Tracking Yacktman Asset Management Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Tue Feb 03, 4:03AM CST
BDX: 146.72 (-1.82), CHRW: 74.30 (+0.09), CLX: 108.64 (-0.46), SYY: 38.99 (-0.15), XOM: 88.54 (-0.11), WMT: 83.93 (+0.13), PDCO: 50.08 (+0.64), PEP: 98.98 (-0.09), ANTM: 146.45 (-0.27), JNJ: 102.51 (-0.29), FOX: 34.04 (+0.25), EBAY: 57.91 (-0.63), FOXA: 35.00 (+0.19), MSFT: 43.85 (-0.21), NWS: 16.82 (-0.04), BK: 39.14 (-0.30), CSCO: 29.51 (-0.40), SYK: 94.75 (+0.35), KO: 43.30 (+0.84), AVP: 8.51 (+0.12), STT: 74.45 (-0.36), BCR: 169.14 (-1.80), UN: 43.47 (+0.22), COP: 65.20 (-0.65), WFC: 54.79 (-0.36), HPQ: 34.84 (+0.83), ORCL: 43.82 (-0.07), USB: 44.61 (-0.32), SIAL: 138.06 (unch), MRK: 58.54 (-0.42), PG: 85.13 (-0.04), VIAB: 69.94 (+0.33), CMCSA: 59.38 (+0.23)
Watch for CR Bard to Potentially Rebound After Falling 3.34% Yesterday
Comtex SmarTrend(R) - Fri Jan 30, 4:13PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $168.83 to a high of $176.49. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $173.53 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.14 (-1.80)
(0)
(0)